Purchase Order 36C77019P0655
- Not listed
- This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration to Tri-Pharma, Inc., a minority-owned small disadvantaged business, for the urgent procurement of the pharmaceutical medication buspirone. The $630,000.00 contract has a completion date of March 14, 2019 and did not utilize a set-aside. Tri-Pharma is a specialty pharmaceutical wholesaler that has been awarded prior prime contracts by the VA, NIH, Indian Health Service, and HHS...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price purchase order to Tri-Pharma, Inc., a minority-owned small disadvantaged business, for the delivery of pharmaceuticals. The $698,075.00 contract does not have a set-aside designation and was completed on June 3, 2019. Tri-Pharma, a specialty pharmaceutical wholesaler, has provided various pharmaceutical products and medical supplies to the VA and Department of Health and Human Services under previous...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price purchase order contract to Tri-Pharma, Inc., a minority-owned small disadvantaged business, to provide pharmaceuticals. The $698,425.00 contract has a completion date of June 3, 2019 and does not include a set-aside designation. Tri-Pharma is a specialty pharmaceutical wholesaler that has provided products such as RYDAPT tablets, fludarabine, and ranitidine to VA medical centers and the NIH Clinical...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Tri-Pharma, Inc., a minority-owned small disadvantaged business, for the delivery of 3,756 bottles of Buspirone HCL 5MG tablets. The $657,300 firm-fixed-price contract was awarded on May 21, 2019 with a completion date of June 10, 2019. The contract was awarded under the VA's Consolidated Mail Out-Patient Pharmacy (CMOP) program, which provides mail-order pharmacy services to...
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Tri-Pharma, Inc., a minority-owned, small disadvantaged business, for the supply of 3,128 units of the pharmaceutical drug BUSPIRONE HCL 15MG TAB. The contract has a firm-fixed price of $547,400.00 and a completion date of June 17, 2019. The contract was a full and open competition with no set-aside. Tri-Pharma has a history of providing pharmaceutical and medical supply products to the VA...
- The Department of Veterans Affairs, Veterans Health Administration awarded a firm-fixed-price purchase order contract to Tri-Pharma, Inc., a self-certified small disadvantaged and Hispanic American-owned business, for $562,100.00. The contract is for the delivery of pharmaceutical products such as RYDAPT tablets, fludarabine, and ranitidine to VA Medical Centers and the NIH Clinical Center. The original solicitation was a pre-solicitation notice that only allowed service-disabled veteran-owned...
- This is a firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Tri-Pharma, Inc., a minority-owned small disadvantaged business, to provide pharmaceutical products. The $244,500.00 contract has a performance period ending on March 25, 2019 and does not have a set-aside designation. Tri-Pharma has provided pharmaceuticals such as RYDAPT tablets, fludarabine, and ranitidine to VA Medical Centers and the NIH Clinical Center under...
- This federal contract award to Tri-Pharma, Inc. (doing business as Tri-Pharma Inc.) was issued by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 17. The $123,374.00 firm-fixed-price purchase order, which has no set-aside designation, is for IV solutions. The contract supports the Hurricane Harvey 2017 National Interest Action. Tri-Pharma is a minority-owned, self-certified small disadvantaged business that specializes in sourcing and...
- The Department of Veterans Affairs Veterans Health Administration has awarded a firm-fixed-price purchase order contract worth $61,142.00 to Tri-Pharma, Inc., a minority-owned, self-certified small disadvantaged business, for the delivery of the pharmaceutical product PHARM - RYDAPT 25 MG SGC 4X28. The contract has a completion date of January 29, 2024. Tri-Pharma, Inc. has extensive experience providing a wide range of pharmaceutical products and medical supplies to various federal agencies,...
- This is a firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Tri-Pharma, Inc., a minority-owned small disadvantaged business. The $87,200.00 contract is for the delivery of solutions for irrigation. The contract has an ultimate completion date of December 29, 2017 and does not have a set-aside designation. Tri-Pharma is a veteran-owned small business that provides pharmaceutical products and medical supplies to various federal agencies, including the...
The Department of Veterans Affairs (VA) awarded a firm-fixed-price purchase order contract worth $562,100.00 to Tri-Pharma, Inc., a minority-owned, self-certified small disadvantaged business, for the delivery of the pharmaceutical drug buspirone. The contract was awarded under VA Network 15's solicitation for pharmaceutical products, which was set aside for service-disabled veteran-owned small businesses (SDVOSB). However, the final award to Tri-Pharma, Inc. did not utilize an SDVOSB set-aside. Tri-Pharma, Inc., doing business as Tri-Pharma Inc., is a specialty pharmaceutical wholesaler that has previously provided pharmaceutical products and personal protective equipment to various government agencies, including the VA and the Department of Health and Human Services.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Buspirone | 36C77019Q0095 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 | Solicitation 1/1 | 11/6/18, 10:53 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 4/12/19 | |
| Not listed | Not listed | $562.1k | 3/21/19 |